首页> 外文期刊>American journal of medical genetics, Part A >Molecularly Proven Mosaicism in Phenotypically Normal Parent of a Girl with Freeman-Sheldon Syndrome Caused by a Pathogenic MYH3 Mutation
【24h】

Molecularly Proven Mosaicism in Phenotypically Normal Parent of a Girl with Freeman-Sheldon Syndrome Caused by a Pathogenic MYH3 Mutation

机译:由致病性MYH3突变引起的Freeman-Sheldon综合征女孩的表型正常父母中的分子证明马赛克

获取原文
获取原文并翻译 | 示例
           

摘要

We report a case of a female child who has classical Freeman-Sheldon syndrome (FSS) associated with a previously reported recurrent pathogenic heterozygous missense mutation, c.2015G>A, p. (Arg672His), in MYH3 where the phenotypically normal mother is a molecularly confirmed mosaic. To the best of our knowledge, this is the first report in the medical literature of molecularly confirmed parental mosaicism for a MYH3 mutation causing FSS. Since proven somatic mosaicism after having an affected child is consistent with gonadal mosaicism, a significantly increased recurrence risk is advised. Parental testing is thus essential for accurate risk assessment for future pregnancies and the use of new technologies with next generation sequencing (NGS) may improve the detection rate of mosaicism. (C) 2016 Wiley Periodicals, Inc.
机译:我们报告了一例患有经典Freeman-Sheldon综合征(FSS)与先前报道的复发性致病性杂合错义突变,c.2015G> A,p的女孩。 (Arg672His),在MYH3中,其中表型正常的母亲是经分子确认的镶嵌体。据我们所知,这是医学文献中有关导致FSS的MYH3突变的分子生物学证实的亲本镶嵌的首次报道。由于患儿患病后经证实的体细胞镶嵌症与性腺镶嵌症相一致,因此建议复发风险显着增加。因此,家长测试对于将来怀孕的准确风险评估至关重要,并且将新技术与下一代测序(NGS)结合使用可以提高镶嵌症的检测率。 (C)2016威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号